Palisade Bio Capital Expenditures (CapEx) Growth & History (PALI)
Palisade Bio's capital expenditures (capex) was $0 for fiscal 2024.
View full Palisade Bio company overviewPalisade Bio annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $0 | −$4,000 | — |
| 2023 | 2023-12-31 | $4,000 | −$6,000 | −60.00% |
| 2022 | 2022-12-31 | $10,000 | $10,000 | — |
| 2021 | 2021-12-31 | $0 | −$6,000 | — |
| 2020 | 2020-12-31 | $6,000 | — | — |
| 2018 | 2018-12-31 | $1,714 | −$9,687 | −84.97% |
| 2017 | 2017-12-31 | $11,401 | −$86,687 | −88.38% |
| 2016 | 2016-12-31 | $98,088 | −$78,184 | −44.35% |
| 2015 | 2015-12-31 | $176,272 | −$31,621 | −15.21% |
| 2014 | 2014-12-31 | $207,893 | $82,531 | +65.83% |
| 2013 | 2013-12-31 | $125,362 | $86,142 | +219.64% |
| 2012 | 2012-12-31 | $39,220 | −$157,192 | −80.03% |
| 2011 | 2011-12-31 | $196,412 | $120,090 | +157.35% |
| 2010 | 2010-12-31 | $76,322 | −$12,056 | −13.64% |
| 2009 | 2009-12-31 | $88,378 | — | — |
Palisade Bio quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q3 2021 | 2021-09-30 | $0 | −$1,000 | — |
| Q3 2020 | 2020-09-30 | $1,000 | — | — |
| Q3 2017 | 2017-09-30 | $1,319 | $1,319 | — |
| Q4 2016 | 2016-12-31 | $0 | −$48,059 | — |
| Q3 2016 | 2016-09-30 | $0 | −$32,194 | — |
| Q2 2016 | 2016-06-30 | $83,490 | $3,523 | +4.41% |
| Q1 2016 | 2016-03-31 | $14,598 | −$1,454 | −9.06% |
| Q4 2015 | 2015-12-31 | $48,059 | $12,337 | +34.54% |
| Q3 2015 | 2015-09-30 | $32,194 | $5,114 | +18.88% |
| Q2 2015 | 2015-06-30 | $79,967 | $45,963 | +135.17% |
| Q1 2015 | 2015-03-31 | $16,052 | −$95,035 | −85.55% |
| Q4 2014 | 2014-12-31 | $35,722 | $29,298 | +456.07% |
| Q3 2014 | 2014-09-30 | $27,080 | −$86,466 | −76.15% |
| Q2 2014 | 2014-06-30 | $34,004 | $30,268 | +810.17% |
| Q1 2014 | 2014-03-31 | $111,087 | $109,431 | +6608.15% |
| Q4 2013 | 2013-12-31 | $6,424 | −$2,593 | −28.76% |
| Q3 2013 | 2013-09-30 | $113,546 | $112,953 | +19047.72% |
| Q2 2013 | 2013-06-30 | $3,736 | −$25,874 | −87.38% |
| Q1 2013 | 2013-03-31 | $1,656 | $1,656 | — |
| Q4 2012 | 2012-12-31 | $9,017 | −$303 | −3.25% |
| Q3 2012 | 2012-09-30 | $593 | −$4,539 | −88.45% |
| Q2 2012 | 2012-06-30 | $29,610 | −$102,181 | −77.53% |
| Q1 2012 | 2012-03-31 | $0 | −$50,169 | — |
| Q4 2011 | 2011-12-31 | $9,320 | — | — |
| Q3 2011 | 2011-09-30 | $5,132 | $3,542 | +222.77% |
| Q2 2011 | 2011-06-30 | $131,791 | — | — |
| Q1 2011 | 2011-03-31 | $50,169 | — | — |
| Q3 2010 | 2010-09-30 | $1,590 | — | — |
Palisade Bio capital expenditures (capex) trends
Between the periods ended 2009-12-31 and 2024-12-31, Palisade Bio's capital expenditures (capex) decreased from $88,378 to $0, a change of −$88,378. The latest reported quarter, Q3 2024, shows $0.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Palisade Bio source filings ↗